Phase 2 Atrial Fibrillation Clinical Trials
14 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–14 of 14 trials
Recruiting
Phase 2
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Atrial Fibrillation (AF)
Regeneron Pharmaceuticals1,200 enrolled37 locationsNCT07175428
Recruiting
Phase 2
SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism
HypertensionAtrial Fibrillation (AF)
Huashan Hospital66 enrolled1 locationNCT07482020
Recruiting
Phase 2
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
Atrial Fibrillation
Novartis Pharmaceuticals165 enrolled30 locationsNCT07217067
Recruiting
Phase 1Phase 2
Anthocyanin-Rich Table Grape Powder for Prophylaxis of Post-Operative Atrial Fibrillation
Post-operative Atrial Fibrillation (POAF)
University of Michigan70 enrolled1 locationNCT05991700
Recruiting
Phase 2
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
ObesityAtrial Fibrillation
The Cleveland Clinic100 enrolled1 locationNCT06802081
Recruiting
Phase 2
Clinical Randomised Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
Atrial Fibrillation (AF)
Acesion Pharma200 enrolled38 locationsNCT07267949
Recruiting
Phase 2
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
Esophageal CarcinomaAtrial Fibrillation
OHSU Knight Cancer Institute90 enrolled1 locationNCT06067438
Recruiting
Phase 2Phase 3
A Study of Stellate Ganglion Block for Prevention of Atrial Fibrillation
Atrial Fibrillation
Mayo Clinic220 enrolled1 locationNCT05357690
Recruiting
Phase 1Phase 2
Amiodarone-Infused CardiaMend Patches for the Prevention of New-Onset POAF in Cardiac Surgery Subjects
Atrial Fibrillation, Postoperative
Helios Cardio Inc.80 enrolled1 locationNCT06730828
Recruiting
Phase 2Phase 3
EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source
Embolic Stroke of Undetermined SourceAtrial Fibrillation New Onset
University of East Anglia100 enrolled1 locationNCT06715449
Recruiting
Phase 2
A Study to Select the Dose and Evaluate the Effectiveness and Safety of the Drug Refralon®, Tablets, 1 mg for Long-term Use to Prevent Recurrence of Atrial Fibrillation/Flutter After Terminating Its Persistent Form
Atrial FibrillationAtrial Flutter
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation200 enrolled1 locationNCT06540352
Recruiting
Phase 2
RiLuzole to Reduce Atrial FIb Study Using Holter Monitoring
Atrial Fibrillation (Paroxysmal)
University of Utah78 enrolled1 locationNCT05292209
Recruiting
Phase 2
Efficacy and Safety of Edoxaban in Patients With Atrial Fibrillation and Mitral Stenosis
Atrial FibrillationStrokeMitral Valve Stenosis+1 more
Sung-Hwan Kim240 enrolled7 locationsNCT05540587
Recruiting
Phase 2
Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot Study
Atrial Fibrillation
University of South Florida40 enrolled1 locationNCT02932007